Nilai pasar assertiotx.com (ASRT)

Logo perusahaan publik Assertio Therapeutics (ASRT)

The market trend for the value of Assertio Holdings, Inc. (ASRT), which specializes in therapies for nervous system disorders, is recorded at 0.15. High barriers to entry in this niche are driven by patent protection and stringent FDA and DEA oversight. While geopolitical tensions limit the export and import of raw materials, optimized supply chains and the stable operation of packaging facilities prevent asset downtime.

ASRT (Assertio Holdings) riwayat Nilai pasar saka 04.07.2022 nganti 27.06.2026

ASRT (assertiotx.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Assertio Holdings, Inc. (ASRT):
Analisis fundamental perusahaan:ASRT (Assertio Therapeutics)
Sampel barang Assertio Holdings

Market capitalization determines the total value of all a company's shares, reflecting the market consensus regarding its fundamental value. This metric aggregates investor expectations, which is clearly demonstrated by the issuer's total market value. The trend of this metric allows for the identification of business degradation risks during price declines. For Assertio Holdings, Inc. (ASRT), this scale is limited by strict FDA and DEA oversight. The neurology patent portfolio creates a defensive barrier that supports the asset's value.

Pesaing wigati

Nilai pasar Biogen BIIB|Kapitalisasi pasar Neurocrine (NBIX)|RGC - Nilai pasar|Nilai pasar AXSM (Axsome Corp)|ACAD (ACADIA Pharmaceuticals) - Biji pasar|XENE: Nilai pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Prothena Corp|Nilai pasar Alector, Inc. (ALEC)|Kapitalisasi pasar Annexon Biosciences|Nilai pasar Omeros OMER|Kapitalisasi pasar Neurogene Therapeutics (NGNE)|AC Immune - Kapitalisasi pasar|Nilai pasar voyagertherapeutics.com|Neumora Therapeutics, Inc. (NMRA) - Nilai pasar|Scilex Holding - Nilai pasar|Biji pasar TVGN|ACOG (Alpha Cognition Corp) - Nilai pasar|Kapitalisasi pasar CGTX|Kapitalisasi pasar inhibikase.com|Nilai pasar Cassava Sciences SAVA|Coya Therapeutics Inc (COYA) - Nilai pasar|VTGN: Biji pasar|Nilai pasar OVID (Ovid Therapeutics Inc.)|ABOS: Kapitalisasi pasar|cervomed.com - Nilai pasar|Nilai pasar Alterity Therapeutics Ltd.|Nilai pasar Clene Nanomedicine CLNN|Nilai pasar PepGen Inc. (PEPG)|Nilai pasar JUNS (jupiterneurosciences.com)|Kapitalisasi pasar RLMD (Relmada Therapeutics)|ANVS: Kapitalisasi pasar|Grace Tx - Kapitalisasi pasar|Kapitalisasi pasar Firefly Neuroscience, Inc. AIFF|anewmeds.com (KLTO) - Nilai pasar|Kapitalisasi pasar NRSN|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|MTVA - Kapitalisasi pasar|Nilai pasar NeurAxis (NRXS)|Kapitalisasi pasar heliusmedical.com|Passage Bio - Biji pasar|Nilai pasar NEUP|Minerva Neurosciences - Kapitalisasi pasar|Kapitalisasi pasar athira.com ATHA|Addex Therapeutics Ltd (ADXN) - Nilai pasar|Kapitalisasi pasar ALZN|CYCN (Cyclerion Therapeutics Inc.) - Kapitalisasi pasar|Biji pasar Protagenic (PTIX)|Biji pasar KTTA (Pasithea Therapeutics)|Kapitalisasi pasar cortigent.com|Kapitalisasi pasar ATXI (Avenue Therapeutics, Inc.)|Kapitalisasi pasar Brainstorm Cell Therapeutics Inc. BCLI|CARA - Nilai pasar|Kapitalisasi pasar Chromocell CHRO|eliemtx.com (ELYM) - Nilai pasar|Intra-Cellular Therapies, Inc. - Nilai pasar|Biji pasar LBPH|MRNS (Marinus Pharmaceuticals Inc) - Nilai pasar|Nilai pasar NKGen (NKGN)|NeuroBo Pharma - Kapitalisasi pasar|Kapitalisasi pasar SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Nilai pasar|TRVN: Biji pasar|VIGL - Kapitalisasi pasar|Anew Medical, Inc. (WENA) - Nilai pasar|Cerevel Corp - Nilai pasar